Douglas Trenkle, DO
Continues to Address Alzheimer's Disease
With Research
Maine Coast Memorial
Hospital’s Douglas Trenkle, DO, who, through
his research has become a specialist in the
care of Alzheimer’s disease patients was
interviewed by WABI reporter Susan Farley.
Along with Dr. Trenkle, his patient Terry
Rohe, a former Good Morning America host
participated in the interview.Below are excerpts
from Dr. Trenkle's Power Point Presentation with data
supporting his procedures.
Detecting
Cognitive Impairment in Primary Care:
Performance Assessment of Three
Screening Instruments*
Douglas L. Trenkle, DO
Maine Coast Memorial Hospital,
Ellsworth, ME, USA
William R. Shankle, MS MD
Dept. of Cognitive Science, UC Irvine,
Irvine, CA, USA
3 Medical Care Corporation, Irvine, CA, USA
Stan
Azen, MD
University of Southern California, CA, USA
*DL Trenkle, DO, R
Shankle, MD, S Azen, MD; Journal of
Alzheimers Disease, in press, 2007
The 10th International
Conference on Alzheimer’s Disease and
Related Disorders
Timeliness of
Diagnosis
- 4 studies have
revealed that in the primary care
setting over 2/3’s of patients with ADRD
are moderate to severely demented when
first diagnosed
- This corresponds
to a time interval from symptom onset to
diagnosis of 9 to 11 years
DA
Bennett, JA Schneider, Z Arvanitikas,
et al. Neurology; 2006; Vol 66
VG
Valcour, KH Masaki, JD Cobb et al.
Arch of Internal Medicine 2000; Vol
160.
B
Reisberg, SH Ferris, EH Franssen et
al. Int Psychogeriatr 1996; Vol 8.
Benefits of
Treating Alzheimers Disease
-
Neurophysiological pathways in patients
with AD are still viable and are a
target for treatment
- Opportunity to
reduce
- Cognitive
decline
- Functional
decline
- Caregiver
burden
Keys to
successful aging
- Avoid common age
related diseases
- Choose active
physical and mental lives
- Social engagement
- Psychological
engagement
- Prevention,
detection and treatment of dementing
illnesses and associated risk factors
Daniel
Kempler, PhD “Neurocognitive Disorders of
Aging,” Chap 14, Sage Publications, 2005
|
|
